-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NAYns+UWINA27fm9KvnJwvDlLDTNojW6xMC38IrfvPLgbsAI02UtdLs2uj/XqXVh +ypdRnUj5NvJVqFm2CaqfQ== 0001181431-05-050932.txt : 20050908 0001181431-05-050932.hdr.sgml : 20050908 20050908144111 ACCESSION NUMBER: 0001181431-05-050932 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050907 FILED AS OF DATE: 20050908 DATE AS OF CHANGE: 20050908 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 BUSINESS PHONE: 805-447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE STREET 2: MAIL STOP 27-3-C CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON FRANKLIN P JR CENTRAL INDEX KEY: 0000904017 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 051075049 BUSINESS ADDRESS: STREET 1: 2275 EAST BAYSHORE ROAD STREET 2: SUITE 1250 CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 6504347400 4 1 rrd91479.xml FORM 4 X0202 4 2005-09-07 0 0000318154 AMGEN INC AMGN 0000904017 JOHNSON FRANKLIN P JR ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 0 0 0 CCPR 4 I By Partnership Common Stock 2005-09-07 4 J 0 50000 0.00 D 350000 I By Partnership Common Stock 2005-09-07 4 J 0 50000 0.00 A 1733061 I Revocable Trust Common Stock 2005-09-07 5 G 0 12500 0 D 1720561 I Revocable Trust (FPJ-CCPR) Contractual contingent payment rights arising from the purchase by Amgen Inc. of four Class A interests of Amgen Clinical Partners, L.P. (FJP 09/05 Dist) On September 7, 2005, Asset Management Partners ("AMP") distributed shares of Amgen Common Stock to a partner of the partnership. Accordingly, 50,000 shares are now held indirectly by the Johnson Revocable Trust. AMP, of which the reporting person is the general partner, currently holds 350,000 shares of Amgen Common Stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. /s/ Franklin P Johnson, Jr. 2005-09-07 -----END PRIVACY-ENHANCED MESSAGE-----